AORT financial statements and SEC filings
AORT annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $441.33M | $33.74M | $9.76M | 10-K |
| 2024-12-31 | $388.54M | $38.87M | -$13.34M | 10-K |
| 2023-12-31 | $354.00M | $5.74M | -$30.57M | 10-K |
| 2022-12-31 | $313.79M | $6.20M | -$19.09M | 10-K |
| 2021-12-31 | $298.84M | $8.12M | -$14.74M | 10-K |
| 2020-12-31 | $253.23M | $2.44M | -$16.57M | 10-K |
AORT annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $884.80M | $436.56M | $448.23M | 10-Q |
| 2024-12-31 | $789.10M | $512.90M | $276.20M | 10-K |
| 2023-12-31 | $792.40M | $510.62M | $281.78M | 10-K |
| 2022-12-31 | $762.80M | $478.47M | $284.33M | 10-K |
| 2021-12-31 | $793.05M | $492.32M | $300.73M | 10-K |
| 2020-12-31 | $789.40M | $460.69M | $328.71M | 10-K |
AORT annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $39.88M | -$39.04M | $11.28M | 10-K |
| 2024-12-31 | $22.24M | -$11.19M | $2.20M | 10-K |
| 2023-12-31 | $18.82M | -$9.75M | $865.00K | 10-K |
| 2022-12-31 | -$5.15M | -$10.71M | -$1.64M | 10-K |
| 2021-12-31 | -$2.58M | -$13.09M | -$12.22M | 10-K |
| 2020-12-31 | $12.37M | -$7.33M | $93.61M | 10-K |